Select data courtesy of the U.S. National Library of Medicine.

© 2026 DeepDyve, Inc. All rights reserved.

This site is protected by VikingCloud's Trusted Commerce program
      Home

    Immunogenetics

    Subject:
    Genetics
    Publisher:
    Springer Berlin Heidelberg — Springer Journals
    ISSN:
    0093-7711
    Scimago Journal Rank:
    95

    2026

    Volume 78
    Issue 1 (Jul)

    2025

    Volume 78
    Issue 1 (Dec)
    Volume 77
    Issue 1 (Dec)

    2024

    Volume 77
    Issue 1 (Nov)
    Volume 76
    Issue 5-6 (Dec)Issue 4 (Aug)Issue 3 (Jun)Issue 2 (Apr)Issue 1 (Feb)

    2023

    Volume 75
    Issue 6 (Dec)Issue 5 (Oct)Issue 4 (Aug)Issue 3 (Jun)Issue 2 (Apr)Issue 1 (Feb)

    2022

    Volume 74
    Issue 6 (Dec)Issue 5 (Oct)Issue 4 (Aug)Issue 3 (Jun)Issue 2 (Apr)Issue 1 (Feb)

    2021

    Volume 73
    Issue 6 (Dec)Issue 5 (Oct)Issue 4 (Mar)Issue 3 (Jun)Issue 2 (Jan)Issue 1 (Jan)

    2020

    Volume 73
    Issue 1 (Nov)
    Volume 72
    Issue 9-10 (Nov)Issue 8 (Oct)Issue 6-7 (Aug)Issue 6 (Sep)Issue 5 (Apr)Issue 4 (May)Issue 3 (Apr)Issue 1-2 (Feb)

    2019

    Volume OnlineFirst
    December
    Volume 71
    Issue 10 (Nov)Issue 9 (Jul)Issue 8 (Sep)Issue 7 (May)Issue 6 (May)Issue 4 (Apr)Issue 3 (Jan)Issue 1 (Jan)

    2018

    Volume 71
    Issue 4 (Dec)Issue 3 (Sep)Issue 2 (Oct)Issue 1 (Oct)
    Volume 70
    Issue 10 (Jul)Issue 9 (Jun)Issue 8 (May)Issue 7 (Mar)Issue 6 (Jun)Issue 3 (Mar)Issue 2 (Feb)Issue 1 (Jan)

    2017

    Volume 70
    Issue 7 (Dec)Issue 6 (Dec)Issue 5 (Oct)Issue 4 (Sep)Issue 3 (Aug)Issue 2 (Jul)Issue 1 (Jul)
    Volume 69
    Issue 10 (Oct)Issue 9 (Jul)Issue 8-9 (Aug)Issue 7 (May)Issue 6 (Mar)Issue 5 (Feb)Issue 4 (Apr)Issue 3 (Jan)

    2016

    Volume 69
    Issue 3 (Nov)Issue 2 (Oct)Issue 1 (Sep)
    Volume 68
    Issue 10 (Aug)Issue 9 (Jun)Issue 8 (Jul)Issue 7 (May)Issue 6 (Jul)Issue 5 (Jan)Issue 4 (Jan)Issue 3 (Mar)Issue 2 (Feb)

    2015

    Volume 68
    Issue 3 (Dec)Issue 2 (Nov)Issue 1 (Sep)
    Volume 67
    Issue 12 (Oct)Issue 11 (Nov)Issue 10 (Sep)Issue 9 (Jul)Issue 8 (Jun)Issue 7 (May)Issue 6 (May)Issue 4 (Mar)Issue 3 (Jan)

    2014

    Volume 67
    Issue 3 (Dec)Issue 2 (Dec)Issue 1 (Nov)
    Volume 66
    Issue 12 (Sep)Issue 11 (Sep)Issue 10 (Jun)Issue 9 (Oct)Issue 8 (May)Issue 7 (Aug)Issue 6 (Jun)Issue 5 (Mar)Issue 4 (Jan)Issue 3 (Jan)Issue 1 (Jan)
    Volume 53
    Issue 9 (Feb)

    2013

    Volume 66
    Issue 3 (Nov)Issue 2 (Nov)Issue 1 (Oct)
    Volume 65
    Issue 12 (Oct)Issue 11 (Aug)Issue 10 (Aug)Issue 9 (Sep)Issue 8 (May)Issue 7 (Apr)Issue 6 (Mar)Issue 5 (Feb)Issue 4 (Feb)Issue 2 (Feb)

    2012

    Volume 65
    Issue 4 (Dec)Issue 3 (Dec)Issue 2 (Nov)Issue 1 (Oct)
    Volume 64
    Issue 12 (Sep)Issue 11 (Aug)Issue 10 (Jul)Issue 9 (Sep)Issue 8 (May)Issue 7 (Jul)Issue 6 (Feb)Issue 5 (Feb)Issue 3 (Jan)Issue 2 (Feb)

    2011

    Volume 64
    Issue 5 (Dec)Issue 4 (Nov)Issue 3 (Sep)Issue 2 (Dec)Issue 1 (Jul)
    Volume 63
    Issue 12 (Dec)Issue 11 (Jun)Issue 10 (Jun)Issue 9 (Jun)Issue 8 (May)Issue 7 (Mar)Issue 6 (Jun)Issue 5 (Feb)Issue 4 (Jan)Issue 3 (Jan)

    2010

    Volume 63
    Issue 4 (Dec)Issue 3 (Dec)Issue 2 (Oct)Issue 1 (Nov)
    Volume 62
    Issue 12 (Sep)Issue 10 (Aug)Issue 9 (Jul)Issue 8 (May)Issue 7 (May)Issue 6 (Apr)Issue 5 (Mar)Issue 4 (Mar)Issue 3 (Feb)Issue 2 (Jan)Issue 1 (Jan)
    Volume 61
    Issue 12 (Jan)

    2009

    Volume 62
    Issue 2 (Dec)Issue 1 (Nov)
    Volume 61
    Issue 12 (Nov)Issue 10 (Sep)Issue 9 (Sep)Issue 8 (Aug)Issue 7 (Jun)Issue 6 (May)Issue 5 (May)Issue 4 (Feb)Issue 3 (Feb)Issue 2 (Jan)

    2008

    Volume 61
    Issue 3 (Dec)Issue 2 (Dec)Issue 1 (Nov)
    Volume 60
    Issue 12 (Oct)Issue 11 (Aug)Issue 10 (Oct)Issue 9 (Jul)Issue 8 (Jun)Issue 7 (Jul)Issue 6 (May)Issue 5 (Apr)Issue 4 (Mar)Issue 2 (Feb)Issue 1 (Jan)

    2007

    Volume 60
    Issue 1 (Dec)
    Volume 59
    Issue 12 (Nov)Issue 11 (Oct)Issue 10 (Sep)Issue 9 (Aug)Issue 8 (Aug)Issue 7 (May)Issue 6 (Apr)Issue 5 (Feb)Issue 4 (Feb)Issue 3 (Mar)Issue 2 (Feb)
    Volume 44
    Issue 6 (Apr)Issue 5 (Apr)Issue 4 (Apr)Issue 3 (Apr)Issue 2 (Jun)Issue 1 (Apr)

    2006

    Volume 59
    Issue 2 (Dec)Issue 1 (Nov)
    Volume 58
    Issue 12 (Dec)Issue 11 (Oct)Issue 10 (Oct)Issue 9 (Aug)Issue 8 (Jun)Issue 7 (Jul)Issue 6 (Apr)Issue 5 (Jun)Issue 4 (May)Issue 3 (Mar)Issue 1 (Feb)
    Volume 57
    Issue 12 (Jan)
    Volume 43
    Issue 5 (Jun)
    Volume 30
    Issue 6 (Apr)Issue 5 (May)Issue 4 (Apr)Issue 3 (Apr)Issue 2 (Apr)Issue 1 (Apr)
    Volume 29
    Issue 1 (Feb)

    2005

    Volume 57
    Issue 12 (Dec)Issue 11 (Dec)Issue 10 (Nov)Issue 9 (Sep)Issue 8 (Aug)Issue 7 (Jul)Issue 6 (Jul)Issue 5 (May)Issue 4 (Apr)Issue 3 (May)Issue 2 (Mar)Issue 1 (Apr)
    Volume 56
    Issue 12 (Jan)Issue 11 (Feb)Issue 10 (Jan)
    Volume 43
    Issue 6 (Sep)
    Volume 40
    Issue 5 (Feb)
    Volume 34
    Issue 6 (May)
    Volume 33
    Issue 3 (May)
    Volume 32
    Issue 3 (Aug)Issue 1 (May)
    Volume 31
    Issue 6 (Aug)
    Volume 12
    Issue 1 (Apr)
    Volume 11
    Issue 1 (Apr)
    Volume 10
    Issue 5 (Apr)Issue 4 (Apr)
    Volume 9
    Issue 1 (Apr)
    Volume 8
    Issue 1 (Apr)
    Volume 7
    Issue 1 (May)
    Volume 6
    Issue 1 (Apr)
    Volume 5
    Issue 1 (Apr)
    Volume 4
    Issue 1 (Apr)
    Volume 3
    Issue 1 (Apr)
    Volume 2
    Issue 1 (Apr)
    Volume 1
    Issue 1 (Apr)

    2004

    Volume 56
    Issue 12 (Dec)Issue 11 (Dec)Issue 10 (Dec)Issue 9 (Nov)Issue 8 (Oct)Issue 7 (Sep)Issue 6 (Sep)Issue 5 (Aug)Issue 4 (Jun)Issue 3 (May)Issue 2 (Apr)Issue 1 (Mar)
    Volume 55
    Issue 12 (Feb)Issue 11 (Jan)Issue 10 (Jan)
    Volume 43
    Issue 4 (Jun)Issue 3 (Jul)Issue 2 (Jul)
    Volume 42
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Jul)Issue 1 (Jun)
    Volume 41
    Issue 6 (Jun)Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Jul)Issue 1 (Jul)
    Volume 40
    Issue 6 (Jul)Issue 4 (Jul)Issue 3 (Jun)Issue 2 (Jul)Issue 1 (Jun)
    Volume 39
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Jul)Issue 1 (Jul)
    Volume 38
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Jul)Issue 1 (Jul)
    Volume 37
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Jul)Issue 1 (Jul)
    Volume 36
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Nov)Issue 2 (Jul)Issue 1 (Jul)
    Volume 35
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jun)Issue 3 (Jul)Issue 2 (Jul)Issue 1 (Jul)
    Volume 34
    Issue 5 (Jul)Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Jul)Issue 1 (Jul)
    Volume 33
    Issue 6 (Jul)Issue 4 (Jul)Issue 2 (Jul)Issue 1 (Jul)
    Volume 32
    Issue 6 (Jul)Issue 5 (Jul)Issue 4 (Jul)Issue 2 (Jul)
    Volume 31
    Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Nov)Issue 1 (Nov)
    Volume 29
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Nov)Issue 3 (Sep)Issue 2 (Sep)
    Volume 28
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 27
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 26
    Issue 6 (Sep)Issue 5 (Sep)Issue 3 (Sep)Issue 2 (Sep)
    Volume 25
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 24
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 23
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 22
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Oct)Issue 1 (Sep)
    Volume 21
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 20
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 19
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 18
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 17
    Issue 6 (Sep)Issue 5 (Nov)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 16
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 15
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Sep)Issue 1 (Sep)
    Volume 14
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 2 (Sep)
    Volume 13
    Issue 6 (Sep)Issue 5 (Sep)Issue 4 (Sep)Issue 3 (Sep)Issue 2 (Oct)

    2003

    Volume 55
    Issue 10 (Dec)Issue 9 (Nov)Issue 8 (Oct)Issue 7 (Aug)Issue 6 (Aug)Issue 5 (Aug)Issue 4 (Jun)Issue 3 (Jun)Issue 2 (Apr)Issue 1 (Mar)
    Volume 54
    Issue 12 (Feb)Issue 11 (Feb)Issue 10 (Jan)

    2002

    Volume 54
    Issue 10 (Dec)Issue 9 (Dec)Issue 8 (Nov)Issue 7 (Oct)Issue 6 (Sep)Issue 5 (Aug)Issue 4 (Jul)Issue 3 (Jun)Issue 2 (May)Issue 1 (Apr)
    Volume 53
    Issue 12 (Feb)Issue 11 (Feb)Issue 10 (Feb)

    2001

    Volume 53
    Issue 9 (Dec)Issue 8 (Oct)Issue 7 (Sep)Issue 6 (Aug)Issue 5 (Jul)Issue 4 (May)Issue 3 (Apr)Issue 2 (Mar)Issue 1 (Feb)
    Volume 52
    Issue 4 (Jan)

    2000

    Volume 52
    Issue 2 (Nov)Issue 1 (Nov)
    Volume 51
    Issue 12 (Oct)Issue 11 (Sep)Issue 10 (Aug)Issue 9 (Jul)Issue 7 (Jun)Issue 6 (May)Issue 5 (Apr)Issue 3 (Mar)Issue 2 (Feb)Issue 1 (Jan)

    1999

    Volume 50
    Issue 6 (Dec)Issue 4 (Nov)Issue 3 (Nov)Issue 2 (Oct)Issue 1 (Oct)
    Volume 49
    Issue 12 (Sep)Issue 11-12 (Sep)Issue 10 (Aug)Issue 9 (Jul)Issue 8 (Jun)Issue 7-8 (Jun)Issue 6 (May)Issue 5 (Apr)Issue 4 (Mar)Issue 3 (Jan)Issue 2 (Feb)Issue 1 (Jan)

    1998

    Volume 48
    Issue 6 (Oct)Issue 5 (Sep)Issue 4 (Aug)Issue 3 (Jul)Issue 2 (Jun)Issue 1 (May)
    Volume 47
    Issue 6 (Apr)Issue 5 (Mar)Issue 4 (Feb)Issue 3 (Jan)

    1997

    Volume 47
    Issue 2 (Dec)Issue 1 (Nov)
    Volume 46
    Issue 6 (Oct)Issue 5 (Sep)Issue 4 (Jul)Issue 3 (Jul)Issue 2 (Jun)Issue 1 (May)
    Volume 45
    Issue 6 (Apr)Issue 5 (Mar)Issue 4 (Jan)Issue 3 (Jan)

    1996

    Volume 45
    Issue 2 (Dec)Issue 1 (Nov)
    Volume 44
    Issue 6 (Oct)Issue 5 (Sep)Issue 4 (Aug)Issue 3 (May)Issue 2 (Mar)Issue 1 (Apr)
    Volume 43
    Issue 6 (Nov)Issue 5 (Mar)

    1995

    Volume 42
    Issue 5 (Sep)
    Volume 41
    Issue 5 (Mar)Issue 4 (Feb)

    1994

    Volume 39
    Issue 2 (Jan)

    1993

    Volume 38
    Issue 4 (Jun)

    1992

    Volume 36
    Issue 5 (Aug)
    Volume 35
    Issue 3 (Feb)

    1990

    Volume 32
    Issue 1 (Jan)

    1989

    Volume 30
    Issue 6 (Dec)Issue 1 (Jul)
    Volume 29
    Issue 3 (Mar)

    1987

    Volume 26
    Issue 4-5 (Jul)Issue 4 (Jul)

    1986

    Volume 24
    Issue 6 (Dec)Issue 1 (Jul)
    Volume 23
    Issue 6 (Jun)Issue 3 (Mar)Issue 2 (Feb)Issue 1 (Jan)

    1985

    Volume 22
    Issue 6 (Dec)
    Volume 21
    Issue 6 (Jun)Issue 5 (May)Issue 3 (Mar)Issue 2 (Feb)

    1984

    Volume 20
    Issue 6 (Dec)Issue 4 (Oct)Issue 3 (Sep)Issue 2 (Aug)Issue 1 (Jul)
    Volume 19
    Issue 5 (May)Issue 1 (Jan)

    1983

    Volume 18
    Issue 6 (Dec)Issue 4 (Oct)Issue 3 (May)
    Volume 17
    Issue 5 (Sep)Issue 1 (Jan)

    1982

    Volume 16
    Issue 6 (Dec)Issue 3 (Sep)
    Volume 15
    Issue 1 (Jan)

    1981

    Volume 14
    Issue 3-4 (Oct)Issue 3 (Oct)
    Volume 13
    Issue 6 (Aug)Issue 3 (May)
    Volume 12
    Issue 1 (Dec)

    1980

    Volume 11
    Issue 1 (Dec)
    Volume 10
    Issue 5 (Oct)Issue 1-4 (Feb)

    1979

    Volume 9
    Issue 1 (Dec)
    Volume 8
    Issue 1 (Dec)

    1978

    Volume 7
    Issue 1 (Dec)
    Volume 6
    Issue 1 (Dec)

    1977

    Volume 5
    Issue 1 (Dec)
    Volume 4
    Issue 1 (Dec)

    1976

    Volume 3
    Issue 1 (Dec)

    1975

    Volume 2
    Issue 1 (Dec)

    1974

    Volume 1
    Issue 1 (Dec)
    journal article
    Open Access Collection
    IPD-MHC: nomenclature requirements for the non-human major histocompatibility complex in the next-generation sequencing era

    Maccari, Giuseppe; Robinson, James; Bontrop, Ronald; Otting, Nel; Groot, Natasja; Ho, Chak-Sum; Ballingall, Keith; Marsh, Steven; Hammond, John

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1072-4pmid: 30027299

    The IPD-MHC Database is the official repository for non-human MHC sequences, overseen and supported by the Comparative MHC Nomenclature Committee, providing access to curated MHC data and associated analysis tools. To address the increasing amount and complexity of data being submitted, an entirely upgraded version of the IPD-MHC Database was recently released to maintain IPD-MHC as the central platform for the comparison of curated MHC data. As a consequence, a new level of nomenclature standardisation is required between the different species to enable data submission and to allow the unambiguous inter- and intra-species comparison of alleles. However, any changes must retain the flexibility demanded by the unique biology of different taxonomic groups. Here, we describe the rationale for a standardised nomenclature system and summarise the changes that have been driven by the requirements of implementing the IPD-MHC database. This modified nomenclature system is essential to maintain the current functionality of IPD-MHC and provide a scalable future-proof database organisation to fully exploit the bioinformatic tools used for analysis.
    journal article
    LitStream Collection
    Comparative MHC nomenclature: report from the ISAG/IUIS-VIC committee 2018

    Ballingall, Keith; Bontrop, Ronald; Ellis, Shirley; Grimholt, Unni; Hammond, John; Ho, Chak-Sum; Kaufman, Jim; Kennedy, Lorna; Maccari, Giuseppe; Miller, Donald; Robinson, James; Marsh, Steven

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1073-3

    journal article
    LitStream Collection
    Human leukocyte antigen (HLA)-C and its association with HIV-1 transmission in discordant couple and mother-to-child cohorts

    Bardeskar, N.; Chavan, V.; Ahir-Bist, S.; Nanavati, R.; Samant-Mavani, P.; Mehta, P.; Mania-Pramanik, Jayanti

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1075-1pmid: 30128812

    Human leukocyte antigen (HLA) molecules play a key role in regulating the immune response towards infectious agents like human immunodeficiency virus type-1 (HIV-1). They have been shown to influence transmission as well as the progression of HIV-1 towards acquired immune deficiency syndrome (AIDS). Roles of HLA-A and HLA-B have been documented extensively; however, HLA-C has been poorly studied. In the present study, we have evaluated the role of HLA-C in discordant couple and mother-to-child cohorts. HLA-C*07 was higher both in HIV-1-infected spouses and infants as compared to exposed uninfected spouses and infants. However, this was not significant. HLA-C*15 was significantly higher in HIV-1-exposed uninfected babies as compared to infected babies. Lack of treatment in mothers and breastfeeding were significantly associated with HIV-1 transmission. HLA-C*07 may be a susceptible allele in HIV-1 transmission, whereas HLA-C*15 may be a protective allele in mother-to-child cohorts, independent of feeding options and treatment. These findings could be important in targeting immune responses via population-specific vaccine strategies against HIV-1.
    journal article
    Open Access Collection
    The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection

    Abels, Wiebke; Manandhar, Trishna; Kunze-Schumacher, Heike; Blasczyk, Rainer; Bade-Döding, Christina

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1077-zpmid: 30128813

    Peptide selection in infected cells is not fully understood yet, but several indications point to the fact that there are differences to uninfected cells, especially in productive HCMV infection, since HCMV evolved various strategies to disable the hosts immune system, including presentation of peptide-HLA complexes to immune effector cells. Therefore, peptide predictions for specific HLA alleles are limited in these cases and the naturally presented peptide repertoire of HCMV-infected cells is of major interest to optimize adoptive T cell therapies. The allotypes HLA-B*35:01 and B*35:08 differ at a single amino acid at position 156 and have been described to differ in their peptide features and in their association with the peptide loading complex. Virus specific T cells recognizing the allelic pHLA-B*35 complexes could be detected, indicating a significant role of this HLA subtypes in viral immunity. However, naturally selected and presented viral peptides have not been described so far. In this study, we analyzed the peptide binding repertoire for HLA-B*35:01 and HLA-B*35:08 in HCMV-infected cells. The isolated peptides from both allelic subtypes were of extraordinary length, however differed in their features, origin, and sequence. For these HCMV-originated peptides, no overlap in the peptide repertoire could be observed between the two allelic subtypes. These findings reveal the discrepancies between predicted and naturally presented immunogenic epitopes and support the need of comprehensive peptide recruitment data for personalized and effective cellular therapies.
    journal article
    LitStream Collection
    HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

    Garrido, María; Rodriguez, Teresa; Zinchenko, Svitlana; Maleno, Isabel; Ruiz-Cabello, Francisco; Concha, Ángel; Olea, Nicolás; Garrido, Federico; Aptsiauri, Natalia

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1074-2pmid: 30145665

    journal article
    Open Access Collection
    The unique evolution of the pig LRC, a single KIR but expansion of LILR and a novel Ig receptor family

    Schwartz, John; Hammond, John

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1067-1pmid: 29931472

    The leukocyte receptor complex (LRC) encodes numerous immunoglobulin (Ig)-like receptors involved in innate immunity. These include the killer-cell Ig-like receptors (KIR) and the leukocyte Ig-like receptors (LILR) which can be polymorphic and vary greatly in number between species. Using the recent long-read genome assembly, Sscrofa11.1, we have characterized the porcine LRC on chromosome 6. We identified a ~ 197-kb region containing numerous LILR genes that were missing in previous assemblies. Out of 17 such LILR genes and fragments, six encode functional proteins, of which three are inhibitory and three are activating, while the majority of pseudogenes had the potential to encode activating receptors. Elsewhere in the LRC, between FCAR and GP6, we identified a novel gene that encodes two Ig-like domains and a long inhibitory intracellular tail. Comparison with two other porcine assemblies revealed a second, nearly identical, non-functional gene encoding a short intracellular tail with ambiguous function. These novel genes were found in a diverse range of mammalian species, including a pseudogene in humans, and typically consist of a single long-tailed receptor and a variable number of short-tailed receptors. Using porcine transcriptome data, both the novel inhibitory gene and the LILR were highly expressed in peripheral blood, while the single KIR gene, KIR2DL1, was either very poorly expressed or not at all. These observations are a prerequisite for improved understanding of immune cell functions in the pig and other species.
    journal article
    LitStream Collection
    Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities

    Fan, Shuhua; Wang, Yongli; Wang, Xian; Huang, Li; Zhang, Yunxia; Liu, Xiaomeng; Zhu, Wenshuai

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1070-6pmid: 29992375

    In vitro refolding assays can be used to investigate the affinity and stability of the binding of epitope peptides to major histocompatibility complex (MHC) class I molecules, which are key factors in the presentation of peptides to cytotoxic T lymphocytes (CTLs). The recognition of peptide epitopes by CTLs is crucial for protection against influenza A virus (IAV) infection. The peptide-binding motif of the swine SLA-3*hs0202 molecule has been previously reported and partly overlaps with the binding motif of the most abundant human MHC allele, HLA-A*0201. In this study, we screened all the protein sequences of the swine-origin epidemic IAV strain A/Beijing/01/2009 (H1N1), and a total of 73 9-mer epitope peptides were predicted to fit the consensus motif of the swine SLA-3*hs0202 or HLA-A*0201 molecule. Then, 14 peptides were selected, and their affinities to SLA-3*hs0202 were tested by a modified in vitro refolding assay. Our results show that ten epitopes could tolerate gel filtration, indicating that these epitopes formed stable or partly stable complexes with SLA-3*hs0202. Eight out of the ten epitopes have been previously reported as HLA-A2-restricted epitopes, which implied cross-reactivity between swine and human MHC I specificities. Furthermore, the modified mini-system refolding method could be applied for the screening of peptides because the refolding efficiency remained almost unchanged with the positive peptide (HA-KMN9) subjected to size-exclusion chromatography and Resource Q anion-exchange chromatography. The results presented here provide new insight into the development of epitope-based vaccines to control IAV and increase our understanding of swine molecular immunology.
    journal article
    LitStream Collection
    Cetacea are natural knockouts for IL20

    Lopes-Marques, Mónica; Machado, André; Barbosa, Susana; Fonseca, Miguel; Ruivo, Raquel; Castro, L.

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1071-5pmid: 29998404

    The Cetacea infraorder comprises a very unique group within the mammalian lineage. While sharing common ancestors with terrestrial mammals, their exclusive dependence on aquatic environments makes them attractive models to explore the landscape of molecular shifts in radical habitat transitions. Among their diverse anatomical and physiological solutions, we find detectable genetic remodeling of the immune system. In agreement, here we show that the gene sequence of interleukin-20 (IL20) displays unambiguous signs of inactivation with several disruptive mutations, including stop codons, insertions, and a conserved trans-species mutation abolishing a canonical splice site, in nine analyzed cetacean genomes. Considering the suggested role of IL20 in skin immunity processes, including inflammation, epithelization, and remodeling, we propose that gene inactivation follows specific adaptations of cetacean skin to the aquatic environment, in frame with the less-is-more hypothesis.
    journal article
    LitStream Collection
    Correction to: Limited MHC class II gene polymorphism in the West African chimpanzee is distributed maximally by haplotype diversity

    Otting, Nel; Groot, Natasja; Bontrop, Ronald

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1089-8pmid: 30283990

    The authors regret that an error was present in the Fig. 5 of the above article; some digits in the DRB allele-designations in Fig. 5 have been lost, and are incorrectly presented by only two digits. The correct allele-designations should have been four (or six) digits. The correct Figure is now presented correctly.
    journal article
    LitStream Collection
    Correction to: Two class I genes of the chicken MHC have different functions: BF1 is recognized by NK cells while BF2 is recognized by CTLs

    Kim, Taejoong; Hunt, Henry; Parcells, Mark; Santen, Vicky; Ewald, Sandra

    2018 Immunogenetics

    doi: 10.1007/s00251-018-1069-zpmid: 29982918

    The Figure 3 in the original version of this article was incorrectly published. In this article the top panel of Figure 3 that describes the amino acid sequence alignment is now added. The original article has been corrected.

    Showing 1 to 10 of 10 Articles

    Articles per page
    Browse All Journals

    Related Journals:

    Nature GeneticsNucleic Acids ResearchGeneticsAnnual Review of GeneticsGenomicsMammalian GenomeChromosome ResearchJournal of GeneticsRussian Journal of Genetics
    pmid:
    30039257
    Significant progress has been made over the last decade in defining major histocompatibility complex (MHC) diversity at the nucleotide, allele, haplotype, diplotype, and population levels in many non-human species. Much of this progress has been driven by the increased availability and reduced costs associated with nucleotide sequencing technologies. This report provides an update on the activities of the comparative MHC nomenclature committee which is a standing committee of both the International Society for Animal Genetics (ISAG) and the International Union of Immunological Societies (IUIS) where it operates under the umbrella of the Veterinary Immunology Committee (VIC). A previous report from this committee in 2006 defined the role of the committee in providing guidance in the development of a standardized nomenclature for genes and alleles at MHC loci in non-human species. It described the establishment of the Immuno Polymorphism Database, IPD-MHC, which continues to provide public access to high quality MHC sequence data across a range of species. In this report, guidelines for the continued development of a universal MHC nomenclature framework are described, summarizing the continued development of each species section within the IPD-MHC project.
    HLA class I (HLA-I) molecules play a crucial role in the presentation of tumor antigenic peptides to CD8+ T cells. Tumor HLA-I loss provides a route of immune escape from T cell-mediated killing. We analyzed HLA-I expression in 98 cryopreserved breast cancer tissues using a broad panel of anti-HLA-I antibodies. Genomic HLA-I typing was performed using DNA obtained from autologous normal breast tissue. Analysis of the loss of heterozygosity (LOH) in the HLA-I region of chromosome 6 (LOH-6) and in the β2-microglobulin (B2M) region of chromosome 15 (LOH-15) was done by microsatellite amplification of DNA isolated from microdissected tumor areas. B2M gene sequencing was done using this DNA form HLA-I-negative tumors. Immunohistological analysis revealed various types of HLA-I alterations in 79 tumors (81%), including total HLA-I loss in 53 cases (54%) and partial loss in 16 samples (14%). In 19 cases (19%), HLA-I expression was positive. Using microsatellite analysis, we detected LOH in 36 cases out of 92 evaluated (39%), including 15 samples with only LOH-6, 14 with LOH-15, and seven tumors with LOH-6 and LOH-15 at the same time. Remarkably, we detected LOH-6 in eight tumors with positive HLA-I immunolabeling. We did not find any B2M mutations in HLA-I-negative breast tumors. In conclusion, LOH at chromosomes 6 and 15 has a high incidence in breast cancer and occurs in tumors with different HLA-I immunophenotypes. This common molecular mechanism of HLA-I alterations may reduce the ability of cytotoxic T lymphocytes  to kill tumor cells and negatively influence the clinical success of cancer immunotherapy.